177 related articles for article (PubMed ID: 35814440)
41. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
Chan KM; Tsai CY; Yeh CN; Yeh TS; Lee WC; Jan YY; Chen MF
BMC Gastroenterol; 2018 Dec; 18(1):180. PubMed ID: 30514231
[TBL] [Abstract][Full Text] [Related]
42. Development and external validation of a prognosis model to predict outcomes after curative resection of early-stage intrahepatic cholangiocarcinoma.
Wang J; Huang M; Shen J; Li B; Wu Y; Xie W; Xiao H; Tan L
Front Surg; 2023; 10():1102871. PubMed ID: 36969753
[TBL] [Abstract][Full Text] [Related]
43. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract][Full Text] [Related]
44. Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma.
Tang Z; Liu WR; Zhou PY; Ding ZB; Jiang XF; Wang H; Tian MX; Tao CY; Fang Y; Qu WF; Dai Z; Qiu SJ; Zhou J; Fan J; Shi YH
J Cancer; 2019; 10(22):5575-5584. PubMed ID: 31632502
[No Abstract] [Full Text] [Related]
45. [The effect of prealbumin on the long-term prognosis of hilar cholangiocarcinoma following radical surgery].
Chen ZY; Liu ZP; Dai HS; Jiang Y; He Y
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):378-386. PubMed ID: 35272430
[No Abstract] [Full Text] [Related]
46. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy.
Wang Y; Li J; Xia Y; Gong R; Wang K; Yan Z; Wan X; Liu G; Wu D; Shi L; Lau W; Wu M; Shen F
J Clin Oncol; 2013 Mar; 31(9):1188-95. PubMed ID: 23358969
[TBL] [Abstract][Full Text] [Related]
47. Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study.
Yu S; You C; Yan R; Chen H; Chen C; Xu S; Gonzalez M; Chen R; Kang M; Chen S
Transl Lung Cancer Res; 2022 Nov; 11(11):2275-2288. PubMed ID: 36519020
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection.
Zhang MX; Gan W; Jing CY; Zheng SS; Zhang J; Shen HJ; Xu X; Lin JJ; Zhang BH; Qiu SJ
Cancer Sci; 2018 Apr; 109(4):1195-1206. PubMed ID: 29446854
[TBL] [Abstract][Full Text] [Related]
49. A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer.
Zheng H; Zhu W; Niu Z; Li H; Zheng Y; Liu Z; Yao J; Lou H; Hu H; Gong L; Pan H; Pan Q
Front Nutr; 2021; 8():664620. PubMed ID: 34760907
[No Abstract] [Full Text] [Related]
50. Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis.
Feng X; Chen W; Tao R; Yuan J; Ruan M; Du J; Guo X; Liu F; Liu H
J Gastrointest Oncol; 2023 Oct; 14(5):2229-2242. PubMed ID: 37969826
[TBL] [Abstract][Full Text] [Related]
51. A Novel Prognostic Nomogram for Patients With Recurrence of Intrahepatic Cholangiocarcinoma After Initial Surgery.
Xing KL; Lu LH; Huang X; He CB; Song YD; Guo RP; Li SP
Front Oncol; 2020; 10():434. PubMed ID: 32300559
[No Abstract] [Full Text] [Related]
52. Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis.
Cheng Z; Lei Z; Jin X; Zhang Q; Si A; Yang P; Zhou J; Hartmann D; Hüser N; Shen F
J Gastrointest Oncol; 2021 Apr; 12(2):819-830. PubMed ID: 34012669
[TBL] [Abstract][Full Text] [Related]
53. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
54. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
[TBL] [Abstract][Full Text] [Related]
55. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
56. High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection.
Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
J Cancer; 2019; 10(5):1313-1324. PubMed ID: 30854141
[TBL] [Abstract][Full Text] [Related]
57. Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study.
Lu J; Xu BB; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Truty MJ; Huang CM
Front Oncol; 2020; 10():574611. PubMed ID: 33194683
[No Abstract] [Full Text] [Related]
58. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
[TBL] [Abstract][Full Text] [Related]
59. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study.
Li H; Liu R; Qiu H; Huang Y; Liu W; Li J; Wu H; Wang G; Li D
Front Oncol; 2022; 12():829407. PubMed ID: 35330712
[TBL] [Abstract][Full Text] [Related]
60. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.
Shen WF; Zhong W; Liu Q; Sui CJ; Huang YQ; Yang JM
World J Surg; 2011 Sep; 35(9):2083-91. PubMed ID: 21698503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
